" class="no-js "lang="en-US"> Oxford/AstraZeneca Alternative Now Available at Riverside Vaccination Centre - Medtech Alert
Sunday, March 26, 2023

Oxford/AstraZeneca Alternative Now Available at Riverside Vaccination Centre

Vaccination appointments are available for residents who are eligible at the Riverside Vaccination Centre in Newport on the Isle of Wight, including those who are aged 30 years and over.

Vaccinations continue to be offered in line with recommendations from the independent JCVI.

If you’re under 40, you’ll be offered a Pfizer appointment as the alternative vaccine to Oxford/AstraZeneca.

If you’re 40 or over, you’ll be asked if you’re pregnant to make sure you’re only shown appointments for the right vaccine for you.

Do not leave Island for jab

Eligible people should book online or call 119. If residents attempt to book online but appointments slots are full, they should continue to keep checking the national booking system as more appointments will become available.

People do not have to travel to the mainland for a vaccination appointment unless they choose to do so.

The Riverside Centre in Newport is open seven days a week, 8am to 8pm and people can choose an appointment slot best suited to them.

Pfizer for Pfizer cohorts 1-9

Continues to be offered to cohorts 1-9 by the Primary Care Networks.

If you receive an invite from your GP, please do act on it as soon as possible so that you can join the millions of people who are helping to protect themselves and others. 

Companies In This Post

  1. Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
  2. Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
  3. Companion Spine Closes $60.1 Million Series A Funding Round Read more
  4. EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
  5. Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more